India’s Serum Institute starts manufacturing Codagenix’s potential COVID-19 vaccine

Codagenix Inc said on Tuesday Serum Institute of India has started manufacturing the U.S. biotech firm’s potential COVID-19 vaccine and it expects to begin early-stage human trial of the vaccine by the end of 2020 in the UK. Serum Institute, the world’s largest vaccine maker by number of doses produced, …

Read moreIndia’s Serum Institute starts manufacturing Codagenix’s potential COVID-19 vaccine